Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PDL BioPharma names new president and CEO
Following the company’s planned separation of its biotechnology and royalty operations, Mr Hasnain will become the president and CEO of the spin-off company, which will be known as
Following the company’s planned separation of its biotechnology and royalty operations, Mr Hasnain will become the president and CEO of the spin-off company, which will be known as
High-dose EPIAO is designed for the rapid restoration of hemoglobin to normal levels among cancer patients. According to the company, the 36,000 IU dosage is comparable to the
In addition to prior experience as a CFO and auditor, Mr Seeman’s background includes managerial roles in compliance testing, managing business controls for accounting, treasury and tax at
Annexin 3, also known as Anxa 3, would be used to provide better identification of patients with a high probability of prostate cancer, thereby reducing the number of
It is reported that the integration of Acambis’s activities strengthens Sanofi Pasteur’s vaccine pipeline of vaccines in development to better answer global health needs. Acambis’s existing manufacturing capabilities
After serving with the company for almost seven years, Dr Pinto will retire from his current position as CEO. He has agreed to remain associated with Pharming and
The company said that it will use the proceeds to continue development of its high potential projects: the commercialization in France and abroad of its first marketable product,
Based in the Alsace BioValley in Strasbourg, the consortium will utilize the pico-liter volumes and ultra-high speed capabilities of RainDance’s technology and systems to achieve breakthrough performance in
The company has appointed Timothy Wentworth as the new group president of employer accounts. Formerly president and CEO of Accredo Health Group, Mr Wentworth will now lead Medco’s
The patent, method for measuring oxidized LDL-CRP complex and measurement kit, describes the binding of oxidized low-density lipoprotein (oxLDL) with C-reactive protein (CRP) resulting in oxLDL/CRP (CRP-AtherOx) complex